GB-6002

· G2GBio, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GB-6002, covering 2024-11-18 to 2024-11-18. Get the full timeline:

Most recent: Clinical Trial Update: Dose-Escalation, Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GB-6002 Local Infiltration in Healthy Male Adults [Phase 1]

See pricing